Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Annika Kasprzak

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Frontiers in Oncology|December 6, 2021
Hybrid or Mixed Myelodysplastic/Myeloproliferative Disorders - Epidemiological Features and OverviewAndrea Kuendgen, Annika Kasprzak, Ulrich Germing
Cancers|April 23, 2022
Assessing the Prognosis of Patients with Myelodysplastic Syndromes (MDS)Annika Kasprzak, Kathrin Nachtkamp, Norbert Gattermann, et al.
Expert Review of Hematology|June 23, 2021
Luspatercept as a therapy for myelodysplastic syndromes with ring sideroblastsFelicitas Schulz, Kathrin Nachtkamp, Annika Kasprzak, et al.
Annals of Hematology|August 22, 2024
MDS patient registries - achievements and challengesTilman Steinmetz, Uwe Totzke, Annika Kasprzak, et al.
International Journal of Environmental Research and Public Health|July 24, 2021
Guidelines for Myelodysplastic Syndromes: Converting Evidence into Action?Annika Kasprzak, Jennifer Kaivers, Kathrin Nachtkamp, et al.
Annals of Hematology|June 10, 2026
Prognostic impact of bone marrow iron and serum ferritin in patients with myelodysplastic syndromesAnnika Kasprzak, Felicitas Schulz, Kathrin Nachtkamp, et al.
Annals of Hematology|January 10, 2025
Outcomes in patients with acute myeloid leukemia older than 70 years within the last 30 years, a single center experienceFelicitas Schulz, Claudia Roggenbuck, Andrea Kündgen, et al.
Scientific Reports|July 4, 2023
Allogeneic hematopoietic stem cell transplantation and pre-transplant strategies in patients with NPM1-mutated acute myeloid leukemia: a single center experiencePaul Jäger, Christina Rautenberg, Jennifer Kaivers, et al.
Cancers|July 29, 2023
The Absolute Monocyte Count at Diagnosis Affects Prognosis in Myelodysplastic Syndromes Independently of the IPSS-R Risk ScoreTobias Silzle, Sabine Blum, Annika Kasprzak, et al.
Cancers|February 24, 2024
Infectious Complications in Patients with Myelodysplastic Syndromes: A Report from the Düsseldorf MDS RegistryAnnika Kasprzak, Julia Andresen, Kathrin Nachtkamp, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Frontiers in Oncology|December 6, 2021
Hybrid or Mixed Myelodysplastic/Myeloproliferative Disorders - Epidemiological Features and OverviewAndrea Kuendgen, Annika Kasprzak, Ulrich Germing
Cancers|April 23, 2022
Assessing the Prognosis of Patients with Myelodysplastic Syndromes (MDS)Annika Kasprzak, Kathrin Nachtkamp, Norbert Gattermann, et al.
Expert Review of Hematology|June 23, 2021
Luspatercept as a therapy for myelodysplastic syndromes with ring sideroblastsFelicitas Schulz, Kathrin Nachtkamp, Annika Kasprzak, et al.
Annals of Hematology|August 22, 2024
MDS patient registries - achievements and challengesTilman Steinmetz, Uwe Totzke, Annika Kasprzak, et al.
International Journal of Environmental Research and Public Health|July 24, 2021
Guidelines for Myelodysplastic Syndromes: Converting Evidence into Action?Annika Kasprzak, Jennifer Kaivers, Kathrin Nachtkamp, et al.
Annals of Hematology|June 10, 2026
Prognostic impact of bone marrow iron and serum ferritin in patients with myelodysplastic syndromesAnnika Kasprzak, Felicitas Schulz, Kathrin Nachtkamp, et al.
Annals of Hematology|January 10, 2025
Outcomes in patients with acute myeloid leukemia older than 70 years within the last 30 years, a single center experienceFelicitas Schulz, Claudia Roggenbuck, Andrea Kündgen, et al.
Scientific Reports|July 4, 2023
Allogeneic hematopoietic stem cell transplantation and pre-transplant strategies in patients with NPM1-mutated acute myeloid leukemia: a single center experiencePaul Jäger, Christina Rautenberg, Jennifer Kaivers, et al.
Cancers|July 29, 2023
The Absolute Monocyte Count at Diagnosis Affects Prognosis in Myelodysplastic Syndromes Independently of the IPSS-R Risk ScoreTobias Silzle, Sabine Blum, Annika Kasprzak, et al.
Cancers|February 24, 2024
Infectious Complications in Patients with Myelodysplastic Syndromes: A Report from the Düsseldorf MDS RegistryAnnika Kasprzak, Julia Andresen, Kathrin Nachtkamp, et al.
Pageof 2